Evidence map›Paper›PMID 31081175›Full record

ArticleJournal of applied clinical medical physics2019

Tolerance levels of mass density for CT number calibration in photon radiation therapy.

Minoru Nakao, Shuichi Ozawa, Katsunori Yogo, Hideharu Miura, Kiyoshi Yamada, Fumika Hosono, Masahiro Hayata, Kentaro Miki, Takeo Nakashima, Yusuke Ochi and 6 more

Abstract read
In one paragraph

Article in Journal of applied clinical medical physics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Minoru NakaoHiroshima High-Precision Radiotherapy Cancer Center, Hiroshima, Japan.
Shuichi OzawaHiroshima High-Precision Radiotherapy Cancer Center, Hiroshima, Japan.
Katsunori YogoDepartment of Radiology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Hideharu MiuraHiroshima High-Precision Radiotherapy Cancer Center, Hiroshima, Japan.
Kiyoshi YamadaHiroshima High-Precision Radiotherapy Cancer Center, Hiroshima, Japan.
Fumika HosonoHiroshima High-Precision Radiotherapy Cancer Center, Hiroshima, Japan.
Masahiro HayataHiroshima High-Precision Radiotherapy Cancer Center, Hiroshima, Japan.
Kentaro MikiDepartment of Radiation Oncology, Institute of Biomedical & Health Science, Hiroshima University, Hiroshima, Japan.
Takeo NakashimaRadiation Therapy Section, Department of Clinical Support, Hiroshima University Hospital, Hiroshima, Japan.
Yusuke OchiRadiation Therapy Section, Department of Clinical Support, Hiroshima University Hospital, Hiroshima, Japan.
Daisuke KawaharaRadiation Therapy Section, Department of Clinical Support, Hiroshima University Hospital, Hiroshima, Japan.
Yoshiharu MorimotoDepartment of Radiology, Hiroshima Prefectural Hospital, Hiroshima, Japan.
Toru YoshizakiRadiation Therapy Department, Hiroshima City Hiroshima Citizens Hospital, Hiroshima, Japan.
Hiroshige NozakiDivision of Radiology, Hiroshima Red Cross Hospital & Atomic-bomb Survivors Hospital, Hiroshima, Japan.
Kosaku HabaraDivision of Radiology, Hiroshima Red Cross Hospital & Atomic-bomb Survivors Hospital, Hiroshima, Japan.
Yasushi NagataHiroshima High-Precision Radiotherapy Cancer Center, Hiroshima, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Computed tomography (CT) data are required to calculate the dose distribution in a patient's body. Generally, there are two CT number calibration methods for commercial radiotherapy treatment planning system (RTPS), namely CT number-relative electron density calibration (CT-RED calibration) and CT number-mass density calibration (CT-MD calibration). In a previous study, the tolerance levels of CT-RED calibration were established for each tissue type. The tolerance levels were established when the relative dose error to local dose reached 2%. However, the tolerance levels of CT-MD calibration are not established yet. We established the tolerance levels of CT-MD calibration based on the tolerance levels of CT-RED calibration. In order to convert mass density (MD) to relative electron density (RED), the conversion factors were determined with adult reference computational phantom data available in the International Commission on Radiological Protection publication 110 (ICRP-110). In order to validate the practicability of the conversion factor, the relative dose error and the dose linearity were validated with multiple RTPSes and dose calculation algorithms for two groups, namely, CT-RED calibration and CT-MD calibration. The tolerance levels of CT-MD calibration were determined from the tolerance levels of CT-RED calibration with conversion factors. The converted RED from MD was compared with actual RED calculated from ICRP-110. The conversion error was within ±0.01 for most standard organs. It was assumed that the conversion error was sufficiently small. The relative dose error difference for two groups was less than 0.3% for each tissue type. Therefore, the tolerance levels for CT-MD calibration were determined from the tolerance levels of CT-RED calibration with the conversion factors. The MD tolerance levels for lung, adipose/muscle, and cartilage/spongy-bone corresponded to ±0.044, ±0.022, and ±0.045 g/cm

Indexed as

AlgorithmsPhantoms, ImagingRadiation ProtectionCalibrationHumansImage Processing, Computer-AssistedOrgans at RiskPhotonsRadiotherapy DosageRadiotherapy Planning, Computer-AssistedTomography, X-Ray ComputedCT number calibrationmass densityphoton radiation therapyradiation treatment planningtolerance level

Identifiers

PMID31081175
PMCPMC6560312

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.